Dretacen

Dretacen is an oral medication containing Levetiracetam, used to manage certain types of seizures. This antiepileptic drug is manufactured by Sandoz B.V. and is available in the EU market.

Dretacen is primarily used as an adjunctive therapy for partial onset seizures in adults and children. It is also prescribed for myoclonic seizures in adults and adolescents. Levetiracetam, the active ingredient, works by affecting certain neurotransmitters in the brain to help control seizure activity. Patients often wonder, 'What is Dretacen used for?' and it is generally prescribed for managing specific types of epilepsy.

Common effects of Dretacen may include drowsiness, dizziness, and fatigue. Some users report headaches or nausea. These effects can vary and are not experienced by everyone. It is important to monitor how the body responds to the medication.

Dretacen should be handled with care, especially for individuals with a history of psychiatric disorders. It is crucial to follow the prescribed dosage and consult a healthcare provider before making any changes. Always store the medication in a cool, dry place away from direct sunlight.

Dretacen may interact with other medications, including certain antidepressants and antiepileptic drugs. Alcohol consumption should be avoided as it can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.